CBLL
CBLL
NASDAQ · Health Care

Ceribell Inc

$18.50
+0.17 (+0.93%)
Financial Highlights (FY 2026)
Revenue
91.01M
Net Income
-54,580,028
Gross Margin
87.9%
Profit Margin
-60.0%
Rev Growth
+50.9%
D/E Ratio
0.13
Revenue & Net Income
Margin Trends
FY 2026 FY 2025 FY 2024 FY 2023
Gross Margin 87.9% 87.9% 62.4% 62.4%
Operating Margin -65.6% -59.0% 9.3% 9.8%
Profit Margin -60.0% -57.0% 7.5% 9.3%
Income Statement
FY 2026 FY 2025 FY 2024 FY 2023
Revenue 91.01M 60.31M 382.61M 402.84M
Gross Profit 79.99M 53.01M 238.74M 251.36M
Operating Income -59,674,622 -35,591,225 35.65M 39.44M
Net Income -54,580,028 -32,552,700 28.84M 37.34M
Gross Margin 87.9% 87.9% 62.4% 62.4%
Operating Margin -65.6% -59.0% 9.3% 9.8%
Profit Margin -60.0% -57.0% 7.5% 9.3%
Rev Growth +50.9% +50.9% +18.2% +23.7%
Balance Sheet
FY 2026 FY 2025 FY 2024 FY 2023
Total Debt 36.95M 36.95M 231.96M 226.82M
Total Equity 289.78M 289.78M 384.45M 368.54M
D/E Ratio 0.13 0.13 0.60 0.62
Cash Flow
FY 2026 FY 2025 FY 2024 FY 2023
EBITDA -51,275,429 -32,280,753 44.83M 44.02M
Free Cash Flow 19.81M 19.16M